MURPHY JOHN RAYMOND 4
4 · Cadrenal Therapeutics, Inc. · Filed Oct 6, 2023
Insider Transaction Report
Form 4
MURPHY JOHN RAYMOND
Director
Transactions
- Purchase
Common Stock
2023-10-04$0.70/sh+17,331$12,132→ 612,123 total - Purchase
Common Stock
2023-10-05$0.69/sh+2,669$1,842→ 614,792 total